How did Dsuvia also known as Sufentanil sublingual receive FDA approval when Scott Gottleib, MD, Commissioner of the FDA acknowledges a "crisis of opioid addiction"?
The opioid is to be administered sublingually (faster absorption) and is approximately
5 to 10 times more potent than its parent drug, Fentanyl.
